Lina Matta
Overview
Explore the profile of Lina Matta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nuckols T, Berdahl C, Henreid A, Schnipper J, Rauf A, Ko E, et al.
Inquiry
. 2023 Dec;
60:469580231218625.
PMID: 38146178
Optimal medication management is important during hospitalization and at discharge because post-discharge adverse drug events (ADEs) are common, often preventable, and contribute to patient harms, healthcare utilization, and costs. Conduct...
2.
Alsowaida Y, Kovacevic M, Belisle C, Cotugno M, Cooley T, Matta L, et al.
Hosp Pharm
. 2022 May;
57(2):211-216.
PMID: 35601721
Executive Quality and Safety WalkRounds (EWRs) is a tool that engages department leadership in discussion with the front-line employees to solicit feedback to improve quality and safety. The purpose of...
3.
Plutzky J, Benson M, Chaney K, Bui T, Kraft M, Matta L, et al.
Am Heart J
. 2021 Sep;
243:15-27.
PMID: 34481756
Background: Implementation of guideline-directed cholesterol management remains low despite definitive evidence establishing such measures reduce cardiovascular (CV) events, especially in high atherosclerotic CV disease (ASCVD) risk patients. Modern electronic resources...
4.
Pevnick J, Keller M, Kennelty K, Nuckols T, Ko E, Amer K, et al.
Contemp Clin Trials
. 2021 May;
106:106419.
PMID: 33932574
Background: Older adults commonly face challenges in understanding, obtaining, administering, and monitoring medication regimens after hospitalization. These difficulties can lead to avoidable morbidity, mortality, and hospital readmissions. Pharmacist-led peri-discharge interventions...
5.
Smith K, Dunning J, Fischer C, MacLean T, Bosque-Hamilton J, Fera L, et al.
J Pharm Pract
. 2021 Apr;
35(5):747-751.
PMID: 33813934
Background: Although strategies for optimization of pharmacologic therapy in patients with heart failure with reduced ejection fraction (HFrEF) are scripted by guidelines, data from HF registries suggests that guideline-directed medical...
6.
Vo P, Sylvia D, Milibari L, Stackhouse J, Szumita P, Rocchio M, et al.
Am J Health Syst Pharm
. 2021 Jan;
78(5):426-435.
PMID: 33471055
Purpose: Management of an acute shortage of parenteral opioid products at a large hospital through prescribing interventions and other guideline-recommended actions is described. Summary: In early 2018, many hospitals were...
7.
Scirica B, Cannon C, Fisher N, Gaziano T, Zelle D, Chaney K, et al.
Circulation
. 2020 Nov;
143(5):507-509.
PMID: 33201729
No abstract available.
8.
Buckley L, Stevenson L, Cooper I, Knowles D, Matta L, Molway D, et al.
J Card Fail
. 2019 Nov;
26(9):798-799.
PMID: 31704197
No abstract available.
9.
Wagholikar K, Fischer C, Goodson A, Herrick C, MacLean T, Smith K, et al.
J Clin Med Res
. 2019 May;
11(6):458-463.
PMID: 31143314
Background: The conventional approach for clinical studies is to identify a cohort of potentially eligible patients and then screen for enrollment. In an effort to reduce the cost and manual...
10.
Schiff G, Tripathi J, Galanter W, Paek J, Pontikes P, Fanikos J, et al.
Am J Health Syst Pharm
. 2019 Mar;
76(8):537-542.
PMID: 30915453
Purpose: An ethnographic study of 3 pharmacy and therapeutics (P&T) committees was conducted to characterize the process by which evidence is weighted and decisions are made. Methods: We recorded discussions...